Product
Cutaquig
1 clinical trial
1 indication
Indication
Primary Immunodeficiency DiseasesClinical trial
Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary ImmunodeficienciesStatus: Recruiting, Estimated PCD: 2023-07-31